免疫組織化学市場レポート：動向、予測、競合分析 (2031年まで)

世界の免疫組織化学市場の将来は、病院・診断検査室、学術・研究機関市場において有望です。世界の免疫組織化学市場は、2025年から2031年までのCAGRが5.4%で、2031年までに推定42億米ドルに達すると予想されます。この市場の主な促進要因は、医療専門家によるデジタルパソロジーの採用の増加、慢性疾患の有病率の上昇、先進国における高齢者人口の急増です。

• Lucintelの予測によると、用途別では、慢性疾患の罹患率の上昇により、診断用途が予測期間中に最も高い成長を遂げる見込みです。
• 最終用途産業別では、病院が診断処置を院内で行う傾向が強まっているため、病院・診断検査室が最大のセグメントであり続けると思われます。
• 地域別では、政府が医療インフラやサービスに多額の投資を行っていることから、APACが予測期間中に最も高い成長を遂げると見られています。

免疫組織化学市場の戦略的成長機会

免疫組織化学市場は、技術の進歩と様々な用途における需要の増加により、いくつかの戦略的成長機会を提示しています。これらの機会がIHCソリューションの将来を形成しています。

• 腫瘍の活用領域の拡大：がんの診断や調査にIHCを用いることには大きな成長の可能性があります。強化されたバイオマーカー検出と新しいアッセイは、より正確ながん診断と個別化治療をサポートしています。
• 自動化ソリューションの開発：市場は自動化されたIHC染色システムの開発に成長機会をもたらしています。自動化は検査室の効率と一貫性を向上させるため、投資と開発の重要な分野となっています。
• デジタル病理学との統合：IHCをデジタル病理ソリューションと統合することで、データ解析と解釈を強化し、成長機会を創出します。この統合は、より効率的で正確な診断と研究をサポートします。
• 新興市場への注力：新興市場への進出は、手頃な価格で地域に密着したIHCソリューションを提供することで成長機会をもたらします。新興市場への進出は、地域のニーズに対応し、市場へのリーチを拡大します。
• 個別化医療における進歩：個別化医療におけるIHCの応用は拡大しており、個々の患者プロファイルに合わせたアッセイを開発する機会があります。この動向は、より的を絞った効果的な治療をサポートします。

このような成長機会は、腫瘍学、自動化、デジタル病理学、新興市場、個別化医療にまたがる免疫組織化学市場の拡大の可能性を強調するものです。これらの分野に資本投下することで、技術革新と市場成長が促進されます。

免疫組織化学市場の促進要因・課題

免疫組織化学市場は、技術進歩、経済要因、規制問題を含む様々な市場促進要因・課題の影響を受けています。これらの要因を理解することは、市場を効果的にナビゲートするために不可欠です。

免疫組織化学市場を牽引する要因は以下の通りです：

• 技術の進歩：マルチプレックスアッセイや高解像度イメージングなど、IHC技術の革新が市場成長の原動力となっています。これらの進歩は診断能力を向上させ、応用分野を拡大します。
• がん罹患率の増加：世界のがん罹患率の上昇により、正確な診断と研究のための高度なIHCソリューションに対する需要が高まっています。こうしたニーズの高まりが市場拡大を支えています。
• 研究開発の成長：研究開発への投資が増加し、IHC製品や技術の革新が促進されています。この投資が新しいアッセイやソリューションの開発を後押ししています。
• 検査室の自動化：自動化されたIHC染色システムの採用により、検査室の効率と一貫性が向上しています。自動化はハイスループット環境をサポートし、生産性を向上させます。
• デジタル病理学との統合：IHCとデジタル病理ソリューションの統合により、データ解析と解釈が進み、診断精度と研究能力が向上しています。

免疫組織化学市場における課題は以下の通りです：

• 高い開発コスト：高度なIHC技術の開発には多額の研究開発費がかかります。中小企業や新興企業にとっては、こうした高コストが障壁となる可能性があります。
• 規制への対応：IHC製品に対する規制要件を満たすことは、特に地域によって困難な場合があります。市場参入と事業運営には、基準へのコンプライアンスを確保することが不可欠です。
• 統合の複雑さ：新しいIHC技術を既存のシステムに統合するのは複雑な場合があります。互換性を確保し、シームレスな運用を実現するには、専門知識と入念な計画が必要となります。
• 市場競争：IHC市場は競争が激しく、数多くの企業が同様の製品を提供しています。競争優位に立つためには、イノベーションとパフォーマンスで差別化を図る必要があります。
• 経済の不確実性：景気の変動や不確実性は、IHC分野の研究開発資金に影響を与える可能性があります。こうした経済的要因は、市場の成長と投資に影響を与える可能性があります。

免疫組織化学市場は、技術の進歩、がん罹患率の増加、自動化などの促進要因によって形成される一方で、高い開発コストや規制遵守などの課題に直面しています。これらの市場促進要因・課題に対処することは、市場の成功と成長にとって極めて重要です。

目次

第1章 エグゼクティブサマリー

第2章 世界の免疫組織化学市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 市場動向と予測分析 (2019年～2031年)

• マクロ経済動向 (2019～2024年) と予測 (2025～2031年)
• 世界の免疫組織化学市場の動向 (2019～2024年) と予測 (2025～2031年)
• 世界の免疫組織化学市場：製品別
  • 抗体
  • 試薬
  • 装置
  • キット
• 世界の免疫組織化学市場：用途別
  • 診断用途
  • 研究用途
  • 法医学用途
• 世界の免疫組織化学市場：最終用途産業別
  • 病院・診断検査室
  • 学術・研究機関
  • その他のエンドユーザー

第4章 地域別の市場動向と予測分析 (2019年～2031年)

• 世界の免疫組織化学市場：地域別
• 北米の免疫組織化学市場
• 欧州の免疫組織化学市場
• アジア太平洋の免疫組織化学市場
• その他地域の免疫組織化学市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 世界の免疫組織化学市場の成長機会：種類別
  • 世界の免疫組織化学市場の成長機会：用途別
  • 世界の免疫組織化学市場の成長機会：最終用途産業別
  • 世界の免疫組織化学市場の成長機会：地域別
• 世界の免疫組織化学市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の免疫組織化学市場の生産能力拡大
  • 世界の免疫組織化学市場における企業合併・買収 (M&A)、合弁事業
  • 認証とライセンシング

第7章 主要企業のプロファイル

• F.Hoffmann-LA-Roche
• Danaher
• Agilent Technologies
• Merck KGAA
• Bio-Rad Laboratories
• Eagle Biosciences
• Biocare Medical
• Elabscience Biotechnology
• Bio-Genex Laboratories
• Diagnostic Biosystem
• Histo-Line Laboratories

The future of the global immunohistochemistry market looks promising with opportunities in the hospitals & diagnostic laboratory, and academic & research institute markets. The global immunohistochemistry market is expected to reach an estimated $4.2 billion by 2031 with a CAGR of 5.4% from 2025 to 2031. The major drivers for this market are the increasing adoption of digital pathology by healthcare professionals, the rising prevalence of chronic diseases, and the surge in the geriatric population in developed countries.

• Lucintel forecasts that, within the application category, diagnostic application is expected to witness the highest growth over the forecast period due to the rising incidence of chronic illnesses.
• Within the end use industry category, hospitals & diagnostic laboratories will remain the largest segment due to increasing trend of hospitals conducting diagnostic procedures in-house.
• In terms of regions, APAC is expected to witness the highest growth over the forecast period due to government is making substantial investments in healthcare infrastructure and services.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Immunohistochemistry Market

The immunohistochemistry market is experiencing key trends driven by technological advancements and increasing demand for precise diagnostics. These trends are shaping the future of IHC applications and solutions.

• Multiplex IHC Assays: Multiplex assays enable the simultaneous detection of multiple biomarkers in a single sample. This trend enhances diagnostic accuracy and research capabilities by providing comprehensive data in one analysis.
• Automated Staining Systems: The adoption of automated IHC staining systems is increasing efficiency and consistency in laboratories. These systems reduce manual errors and improve reproducibility, making them crucial for high-throughput environments.
• AI and Machine Learning Integration: AI and machine learning are being integrated into IHC image analysis, enhancing the accuracy of biomarker detection and interpretation. These technologies enable more precise and faster data analysis.
• Enhanced Imaging Techniques: High-resolution imaging techniques are advancing, providing more detailed and accurate visualization of tissue samples. These techniques support better diagnostics and research outcomes by improving biomarker detection.
• Localized Solutions and Cost Reduction: There is a focus on developing localized IHC solutions to address regional needs and reduce costs. This trend aims to make IHC more accessible and affordable in emerging markets.

These trends are reshaping the immunohistochemistry market by improving diagnostic precision, efficiency, and accessibility. The focus on multiplex assays, automation, AI integration, enhanced imaging, and localized solutions is driving innovation and expanding the applications of IHC technologies.

Recent Developments in the Immunohistochemistry Market

Recent developments in the immunohistochemistry market highlight advancements in technology, automation, and regional growth. These developments are enhancing the capabilities and applications of IHC in diagnostics and research.

• Introduction of Multiplex IHC Assays: New multiplex IHC assays allow for the detection of multiple biomarkers simultaneously, improving diagnostic accuracy and research efficiency. This development supports a more comprehensive analysis of complex diseases.
• Advancement in Automated Staining Systems: Automation in IHC staining systems is increasing, with new systems offering higher throughput and consistency. These advancements reduce manual errors and streamline laboratory workflows.
• Integration of AI in Image Analysis: AI technologies are being incorporated into IHC image analysis, improving the accuracy of biomarker detection and data interpretation. This integration enhances research and diagnostic precision.
• Development of High-Resolution Imaging Techniques: High-resolution imaging techniques are advancing, providing more detailed visualization of tissue samples. This development supports better biomarker detection and enhances diagnostic capabilities.
• Expansion of Localized IHC Solutions: There is a growing focus on developing localized IHC solutions to meet regional needs and reduce costs. This expansion is making IHC more accessible in emerging markets.

These developments are advancing the immunohistochemistry market by enhancing diagnostic capabilities, improving efficiency, and expanding accessibility. Innovations in multiplex assays, automation, AI integration, high-resolution imaging, and localized solutions are driving progress in this field.

Strategic Growth Opportunities for Immunohistochemistry Market

The immunohistochemistry market presents several strategic growth opportunities driven by technological advancements and increasing demand across various applications. These opportunities are shaping the future of IHC solutions.

• Expansion in Oncology Applications: There is significant growth potential in using IHC for cancer diagnostics and research. Enhanced biomarker detection and new assays are supporting more accurate cancer diagnoses and personalized treatments.
• Development of Automated Solutions: The market offers growth opportunities in developing automated IHC staining systems. Automation improves laboratory efficiency and consistency, making it a key area for investment and development.
• Integration with Digital Pathology: Integrating IHC with digital pathology solutions creates growth opportunities by enhancing data analysis and interpretation. This integration supports more efficient and accurate diagnostics and research.
• Focus on Emerging Markets: Expanding into emerging markets presents growth opportunities by providing affordable and localized IHC solutions. This expansion addresses regional needs and increases market reach.
• Advancements in Personalized Medicine: The application of IHC in personalized medicine is growing, with opportunities to develop assays tailored to individual patient profiles. This trend supports more targeted and effective treatments.

These growth opportunities highlight the potential for expanding the immunohistochemistry market across oncology, automation, digital pathology, emerging markets, and personalized medicine. Capitalizing on these areas will drive innovation and market growth.

Immunohistochemistry Market Driver and Challenges

The immunohistochemistry market is influenced by various drivers and challenges, including technological advancements, economic factors, and regulatory issues. Understanding these factors is essential for navigating the market effectively.

The factors responsible for driving the immunohistochemistry market include:

• Technological Advancements: Innovations in IHC technology, such as multiplex assays and high-resolution imaging, are driving market growth. These advancements improve diagnostic capabilities and expand application areas.
• Increasing Cancer Incidence: The rising incidence of cancer globally is driving demand for advanced IHC solutions for accurate diagnostics and research. This growing need supports market expansion.
• Growth in Research and Development: Increased investment in research and development is fostering innovation in IHC products and technologies. This investment drives the development of new assays and solutions.
• Automation in Laboratories: The adoption of automated IHC staining systems is improving efficiency and consistency in laboratories. Automation supports high-throughput environments and enhances productivity.
• Integration with Digital Pathology: Integrating IHC with digital pathology solutions is advancing data analysis and interpretation, enhancing diagnostic accuracy and research capabilities.

Challenges in the immunohistochemistry market are:

• High Development Costs: Developing advanced IHC technologies involves significant research and development costs. These high costs can be a barrier for smaller companies and startups.
• Regulatory Compliance: Meeting regulatory requirements for IHC products, particularly in different regions, can be challenging. Ensuring compliance with standards is essential for market entry and operation.
• Complexity of Integration: Integrating new IHC technologies with existing systems can be complex. Ensuring compatibility and seamless operation requires expertise and careful planning.
• Market Competition: The IHC market is competitive, with numerous players offering similar products. Companies must differentiate themselves through innovation and performance to gain a competitive edge.
• Economic Uncertainties: Economic fluctuations and uncertainties can impact funding for research and development in the IHC sector. These economic factors can affect market growth and investment.

The immunohistochemistry market is shaped by drivers such as technological advancements, increasing cancer incidence, and automation, while facing challenges like high development costs and regulatory compliance. Addressing these drivers and challenges is crucial for success and growth in the market.

List of Immunohistochemistry Companies

Companies in the market compete based on product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, immunohistochemistry companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the immunohistochemistry companies profiled in this report include-

• F.Hoffmann-LA-Roche
• Danaher
• Agilent Technologies
• Merck KGAA
• Bio-Rad Laboratories
• Eagle Biosciences
• Biocare Medical
• Elabscience Biotechnology
• Bio-Genex Laboratories
• Diagnostic Biosystem

Immunohistochemistry by Segment

The study includes a forecast for the global immunohistochemistry market by product, application, end use industry, and region.

Immunohistochemistry Market by Product [Analysis by Value from 2019 to 2031]:

• Antibodies
• Reagents
• Equipment
• Kits

Immunohistochemistry Market by Application [Analysis by Value from 2019 to 2031]:

• Diagnostic Applications
• Research Applications
• Forensic Applications

Immunohistochemistry Market by End Use Industry [Analysis by Value from 2019 to 2031]:

• Hospitals & Diagnostic Laboratories
• Academic & Research Institutes
• Other End Users

Immunohistochemistry Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Immunohistochemistry Market

Major players in the market are expanding their operations and forming strategic partnerships to strengthen their positions. Below are recent developments by major immunohistochemistry producers in key regions: the USA, China, India, Japan, and Germany.

• United States: In the U.S., significant advancements include the introduction of multiplex IHC assays that allow for simultaneous detection of multiple biomarkers. This development enhances diagnostic accuracy and research capabilities, particularly in oncology and neurology.
• China: China is focusing on improving the quality and cost-efficiency of IHC products. The country is seeing growth in domestic production of IHC reagents and antibodies, leading to increased availability and affordability of these tools for research and clinical applications.
• Germany: Germany is leading innovations in automated IHC staining systems, which enhance throughput and consistency in laboratories. These systems are becoming more sophisticated, incorporating artificial intelligence for better image analysis and data interpretation.
• India: India is witnessing increased adoption of IHC in diagnostic laboratories due to a rise in cancer cases. There is also a push towards developing localized IHC solutions to meet specific regional needs and improve healthcare accessibility.
• Japan: Japan is advancing in the development of high-resolution IHC imaging techniques. These techniques improve the detection and quantification of biomarkers, supporting more precise diagnostics and research in various disease areas.

Features of the Global Immunohistochemistry Market

Market Size Estimates: Immunohistochemistry market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Immunohistochemistry market size by various segments, such as by product, application, end use industry, and region in terms of value ($B).

Regional Analysis: Immunohistochemistry market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, applications, end use industries, and regions for the immunohistochemistry market.

Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the immunohistochemistry market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the immunohistochemistry market by product (antibodies, reagents, equipment, and kits), application (diagnostic applications, research applications, and forensic applications), end use industry (hospitals & diagnostic laboratories, academic & research institutes, and other end users), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Immunohistochemistry Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Immunohistochemistry Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Immunohistochemistry Market by Product
  • 3.3.1: Antibodies
  • 3.3.2: Reagents
  • 3.3.3: Equipment
  • 3.3.4: Kits
• 3.4: Global Immunohistochemistry Market by Application
  • 3.4.1: Diagnostic Applications
  • 3.4.2: Research Applications
  • 3.4.3: Forensic Applications
• 3.5: Global Immunohistochemistry Market by End Use Industry
  • 3.5.1: Hospitals & Diagnostic Laboratories
  • 3.5.2: Academic & Research Institutes
  • 3.5.3: Other end users

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Immunohistochemistry Market by Region
• 4.2: North American Immunohistochemistry Market
  • 4.2.1: North American Market by Application: Diagnostic applications, Research applications, and Forensic applications
  • 4.2.2: North American Market by End Use Industry: Hospitals & Diagnostic Laboratories, Academic & research Institutes, and Other end users
• 4.3: European Immunohistochemistry Market
  • 4.3.1: European Market by Application: Diagnostic applications, Research applications, and Forensic applications
  • 4.3.2: European Market by End Use Industry: Hospitals & Diagnostic Laboratories, Academic & research Institutes, and Other end users
• 4.4: APAC Immunohistochemistry Market
  • 4.4.1: APAC Market by Application: Diagnostic applications, Research applications, and Forensic applications
  • 4.4.2: APAC Market by End Use Industry: Hospitals & Diagnostic Laboratories, Academic & research Institutes, and Other end users
• 4.5: ROW Immunohistochemistry Market
  • 4.5.1: ROW Market by Application: Diagnostic applications, Research applications, and Forensic applications
  • 4.5.2: ROW Market by End Use Industry: Hospitals & Diagnostic Laboratories, Academic & research Institutes, and Other end users

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Immunohistochemistry Market by Product
  • 6.1.2: Growth Opportunities for the Global Immunohistochemistry Market by Application
  • 6.1.3: Growth Opportunities for the Global Immunohistochemistry Market by End Use Industry
  • 6.1.4: Growth Opportunities for the Global Immunohistochemistry Market by Region
• 6.2: Emerging Trends in the Global Immunohistochemistry Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Immunohistochemistry Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Immunohistochemistry Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: F.Hoffmann-LA-Roche
• 7.2: Danaher
• 7.3: Agilent Technologies
• 7.4: Merck KGAA
• 7.5: Bio-Rad Laboratories
• 7.6: Eagle Biosciences
• 7.7: Biocare Medical
• 7.8: Elabscience Biotechnology
• 7.9: Bio-Genex Laboratories
• 7.10: Diagnostic Biosystem
• 7.11: Histo-Line Laboratories